Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Schrödinger, Inc. (NASDAQ:SDGR) has received a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $32.90.

A number of research analysts have recently commented on SDGR shares. Morgan Stanley cut their price objective on shares of Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 21st. BMO Capital Markets upped their price target on Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th.

Insider Activity

In other news, insider Margaret Dugan sold 1,531 shares of the company’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $17.78, for a total value of $27,221.18. Following the sale, the insider now owns 13,469 shares of the company’s stock, valued at approximately $239,478.82. This represents a 10.21 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 8.60% of the company’s stock.

Hedge Funds Weigh In On Schrödinger

Institutional investors have recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its holdings in shares of Schrödinger by 5.0% during the third quarter. Harbor Capital Advisors Inc. now owns 13,059 shares of the company’s stock worth $242,000 after buying an additional 622 shares in the last quarter. Louisiana State Employees Retirement System increased its holdings in Schrödinger by 2.6% during the 2nd quarter. Louisiana State Employees Retirement System now owns 27,800 shares of the company’s stock valued at $538,000 after purchasing an additional 700 shares in the last quarter. KBC Group NV raised its position in Schrödinger by 45.4% in the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after purchasing an additional 783 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in Schrödinger by 145.3% in the second quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company’s stock worth $27,000 after purchasing an additional 837 shares in the last quarter. Finally, Ensign Peak Advisors Inc grew its holdings in shares of Schrödinger by 4.1% during the second quarter. Ensign Peak Advisors Inc now owns 23,893 shares of the company’s stock worth $462,000 after purchasing an additional 950 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Schrödinger Trading Up 3.9 %

NASDAQ SDGR opened at $21.64 on Tuesday. Schrödinger has a 1 year low of $16.67 and a 1 year high of $38.00. The company has a fifty day simple moving average of $19.60 and a 200 day simple moving average of $20.10. The company has a market cap of $1.58 billion, a P/E ratio of -9.25 and a beta of 1.56.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). The firm had revenue of $35.30 million for the quarter, compared to the consensus estimate of $41.25 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The firm’s revenue was down 17.1% on a year-over-year basis. During the same quarter last year, the company earned ($0.86) earnings per share. Equities research analysts forecast that Schrödinger will post -2.29 EPS for the current fiscal year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.